CHICAGO -- Brensocatib (Brinsupri) appeared to have a disease-modifying effect on structural lung changes in non-cystic fibrosis bronchiectasis at its higher dose, a CT substudy of the ASPEN trial ...

Dr. Christopher J. Richards: A 47-year-old woman was evaluated at the outpatient pulmonary clinic of this hospital because of recurrent sinusitis with progressive cough and bronchiectasis. Since her ...

How finally accepting her diagnosis and being proactive with her health helped one woman manage her lung condition.

Brensocatib, newly approved by the FDA for noncystic fibrosis bronchiectasis (NCFB), was also associated with improvements in lung structure, on the basis of data from a substudy of 100 individuals ...

Bronchiectasis is a lung condition that causes a persistent cough and excess phlegm, or sputum. It is a permanent condition that gets worse over time. It can be fatal. The bronchi dilate, usually ...

Trajectory of patient outcomes for those diagnosed with bronchiectasis is explored by Dr Metersky. This is a video synopsis/summary of an Insights involving Mark Metersky, MD, FCCP, on the prognosis ...